Your browser doesn't support javascript.
loading
Risk-Prediction Model for Transfusion of Erythrocyte Concentrate During Extracorporeal Circulation in Coronary Surgery
Paiva, Patrícia Pinheiro; Leite, Filipe Miguel; Antunes, Pedro E.; Antunes, Manuel J..
  • Paiva, Patrícia Pinheiro; Hospital and University Centre of Coimbra. Department of Clinical Pharmacology. Coimbra. PT
  • Leite, Filipe Miguel; Hospital and University Centre of Coimbra. Department of Cardiothoracic Surgery. Coimbra. PT
  • Antunes, Pedro E.; Hospital and University Centre of Coimbra. Department of Cardiothoracic Surgery. Coimbra. PT
  • Antunes, Manuel J.; University of Coimbra Faculty of Medicine. Department of Cardiothoracic Surgery. Coimbra. PT
Rev. bras. cir. cardiovasc ; 36(3): 323-330, May-June 2021. tab, graf
Article in English | LILACS | ID: biblio-1288251
ABSTRACT
Abstract

Introduction:

Our objective was to identify preoperative risk factors and to develop and validate a risk-prediction model for the need for blood (erythrocyte concentrate [EC]) transfusion during extracorporeal circulation (ECC) in patients undergoing coronary artery bypass grafting (CABG).

Methods:

This is a retrospective observational study including 530 consecutive patients who underwent isolated on-pump CABG at our Centre over a full two-year period. The risk model was developed and validated by logistic regression and bootstrap analysis. Discrimination and calibration were assessed using the area under the receiver operating characteristic curve (AUC) and the Hosmer-Lemeshow (H-L) test, respectively.

Results:

EC transfusion during ECC was required in 91 patients (17.2%). Of these, the majority were transfused with one (54.9%) or two (41.8%) EC units. The final model covariates (reported as odds ratios; 95% confidence interval) were age (1.07; 1.02-1.13), glomerular filtration rate (0.98; 0.96-1.00), body surface area (0.95; 0.92-0.98), peripheral vascular disease (3.03; 1.01-9.05), cerebrovascular disease (4.58; 1.29-16.18), and hematocrit (0.55; 0.48-0.63). The risk model developed has an excellent discriminatory power (AUC 0,963). The results of the H-L test showed that the model predicts accurately both on average and across the ranges of deciles of risk.

Conclusions:

A risk-prediction model for EC transfusion during ECC was developed, which performed adequately in terms of discrimination, calibration, and stability over a wide spectrum of risk. It can be used as an instrument to provide accurate information about the need for EC transfusion during ECC, and as a valuable adjunct for local improvement of clinical practice. OR=odds ratio Key Question What is the risk of the need for use of erythrocyte concentrate (EC) during cardiopulmonary bypass? Key

Findings:

Risk factors with the greatest prediction for EC transfusion. Take-Home Message The implementation of this model would be an important step in optimizing and improving the quality of surgery.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Cardiac Surgical Procedures Type of study: Etiology study / Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Rev. bras. cir. cardiovasc Journal subject: Cardiology / General Surgery Year: 2021 Type: Article Affiliation country: Portugal Institution/Affiliation country: Hospital and University Centre of Coimbra/PT / University of Coimbra Faculty of Medicine/PT

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Cardiac Surgical Procedures Type of study: Etiology study / Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Rev. bras. cir. cardiovasc Journal subject: Cardiology / General Surgery Year: 2021 Type: Article Affiliation country: Portugal Institution/Affiliation country: Hospital and University Centre of Coimbra/PT / University of Coimbra Faculty of Medicine/PT